SOA Wealth Advisors LLC. Buys 106,319 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

SOA Wealth Advisors LLC. boosted its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 42,190.1% in the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 106,571 shares of the exchange traded fund’s stock after purchasing an additional 106,319 shares during the quarter. SPDR S&P Biotech ETF comprises 1.0% of SOA Wealth Advisors LLC.’s portfolio, making the stock its 25th largest holding. SOA Wealth Advisors LLC. owned approximately 0.17% of SPDR S&P Biotech ETF worth $8,643,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors have also recently added to or reduced their stakes in XBI. Demars Financial Group LLC bought a new stake in SPDR S&P Biotech ETF during the fourth quarter worth approximately $280,309,000. BlueCrest Capital Management Ltd bought a new stake in SPDR S&P Biotech ETF during the fourth quarter worth approximately $138,051,000. RA Capital Management L.P. bought a new stake in SPDR S&P Biotech ETF during the fourth quarter worth approximately $110,615,000. Proficio Capital Partners LLC boosted its position in SPDR S&P Biotech ETF by 16,156.1% during the fourth quarter. Proficio Capital Partners LLC now owns 917,329 shares of the exchange traded fund’s stock worth $82,615,000 after purchasing an additional 911,686 shares during the period. Finally, Raymond James Financial Inc. acquired a new position in shares of SPDR S&P Biotech ETF during the fourth quarter worth approximately $55,529,000.

SPDR S&P Biotech ETF Trading Up 2.1%

XBI opened at $84.26 on Friday. SPDR S&P Biotech ETF has a 1-year low of $66.66 and a 1-year high of $105.47. The stock has a market capitalization of $4.99 billion, a price-to-earnings ratio of 11.47 and a beta of 0.85. The business has a 50 day moving average of $78.33 and a 200-day moving average of $86.66.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.